Solgar Glucosamine Chondroitin Recalled Due to Wrong Product Packaging Error
Nestle Health Science recalled Solgar Glucosamine Chondroitin (120-tablet bottles) distributed in six states due to a packaging error where Megasorb B-Complex was filled into mislabeled bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III classification with no reported illnesses, injuries, or deaths. The recall addresses a product substitution and labeling error rather than a contamination or safety hazard.
Plain-English summary
Nestle Health Science has recalled Solgar Glucosamine Chondroitin, 120 Tablets per bottle (glass bottles, 12 per case), due to a packaging error. During production, bottles labeled as Glucosamine Chondroitin MSM were incorrectly filled with Megasorb B-Complex product instead of the labeled glucosamine formulation.
The recalled product was distributed in six U.S. states: New York, Indiana, Pennsylvania, Texas, Tennessee, and Nevada. The affected lot number is 3250UM0704 with UPC Code 041260351211. A total of 612 bottles are subject to this recall.
Consumers who have purchased bottles with the affected lot number and UPC code should not use the product and should contact the manufacturer or retailer for information regarding product returns or disposal.
The recalled product
- Product
- Solgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle. Glass Bottle, 12 per Case, Store at room temperature . Product Number -1319
- Manufacturer
- Nestle Product Technology Center - Nestle Health Science
- Category
- Drug — Dietary Supplement
- Hazard
- product-substitution
- mislabeling
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot/Unit Numbers: 3250UM0704 UPC Codes: 041260351211
Distribution
Distributed in 6 states:
- IN
- NV
- NY
- PA
- TN
- TX
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27